Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK.
Int J Environ Res Public Health. 2019 Feb 8;16(3):485. doi: 10.3390/ijerph16030485.
Many suggested policy interventions for childhood and adolescent obesity have costs and effects that fall outside the health care sector. These cross-sectorial costs and consequences have implications for how economic evaluation is applied and although previous systematic reviews have provided a summary of cost-effectiveness, very few have conducted a review of methods applied. We undertook this comprehensive review of economic evaluations, appraising the methods used, assessing the quality of the economic evaluations, and summarising cost-effectiveness. Nine electronic databases were searched for full-economic evaluation studies published between January 2001 and April 2017 with no language or country restrictions. 39 economic evaluation studies were reviewed and quality assessed. Almost all the studies were from Western countries and methods were found to vary by country, setting and type of intervention. The majority, particularly "behavioural and policy" preventive interventions, were cost-effective, even cost-saving. Only four interventions were not cost effective. This systematic review suggests that economic evaluation of obesity interventions is an expanding area of research. However, methodological heterogeneity makes evidence synthesis challenging. Whilst upstream interventions show promise, an expanded and consistent approach to evaluate cost-effectiveness is needed to capture health and non-health costs and consequences.
许多针对儿童和青少年肥胖的政策干预措施都有超出医疗保健部门的成本和影响。这些跨部门的成本和后果对经济评估的应用方式有影响,尽管之前的系统评价已经对成本效益进行了总结,但很少有对所应用方法进行评价的。我们对经济评估进行了全面审查,评估了所使用的方法,评估了经济评估的质量,并总结了成本效益。在 2001 年 1 月至 2017 年 4 月期间,我们在九个电子数据库中搜索了没有语言或国家限制的全文经济评估研究。共审查和质量评估了 39 项经济评估研究。几乎所有的研究都来自西方国家,而且研究方法因国家、环境和干预类型而异。大多数研究,特别是“行为和政策”预防干预措施,是具有成本效益的,甚至是节省成本的。只有四种干预措施不具有成本效益。这项系统评价表明,肥胖干预措施的经济评价是一个不断发展的研究领域。然而,方法上的异质性使得证据综合具有挑战性。虽然上游干预措施显示出了前景,但需要采用一种扩展和一致的方法来评估成本效益,以捕捉健康和非健康成本和后果。